IS DIASTOLIC DYSFUNCTION ASSOCIATED WITH THROMBOGENESIS - A STUDY OF CIRCULATING MARKERS OF A PROTHROMBOTIC STATE IN PATIENTS WITH CORONARY-ARTERY DISEASE

被引:16
作者
LIP, GYH
LOWE, GDO
METCALFE, MJ
RUMLEY, A
DUNN, FG
机构
[1] STOBHILL GEN HOSP,DEPT CARDIOL,GLASGOW G21 3UW,LANARK,SCOTLAND
[2] UNIV GLASGOW,ROYAL INFIRM,DEPT MED,HAEMOSTASIS THROMBOSIS & VASC MED UNIT,GLASGOW G31 2ER,LANARK,SCOTLAND
关键词
DIASTOLIC DYSFUNCTION; FIBRINOGEN; D-DIMER; VON WILLEBRAND FACTOR;
D O I
10.1016/0167-5273(95)02327-S
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Clinical data on the contributory role of heart failure to thromboembolic risk does not differentiate between systolic and diastolic left ventricular dysfunction. We therefore conducted a population-controlled cross-sectional study to determine levels of plasma fibrinogen (associated with thromboembolism), fibrin D-dimer (a marker of fibrin turnover) and von Willebrand factor (a marker of endothelial dysfunction) in patients with ischaemic heart disease (a common cause of diastolic dysfunction) in whom left ventricular diastolic function was defined by echocardiography. We studied 106 patients: those with normal left ventricular function (n = 42, Group 1); those with left ventricular dysfunction but without aneurysms (n = 34, Group 2); and those with left ventricular aneurysm formation (n = 30, Group 3). Each of these groups was subdivided into those with (a) and without (b) diastolic dysfunction. Diastolic dysfunction was present in over 60% of patients, irrespective of left ventricular systolic impairment. There were no significant differences in median levels of plasma fibrinogen, fibrin D-dimer or von Willebrand factor in each group of patients with ischaemic heart disease, whether or not left ventricular diastolic dysfunction was present (Mann-Whitney test; P = N.S.). Systolic (rather than diastolic) dysfunction was the main correlate of these (analysis of variance, general linear model - ANOVA-GLM - P < 0.05) and the greatest abnormalities of fibrinogen, endothelial dysfunction and intravascular fibrin turnover were seen in patients with left ventricular aneurysms whether or not diastolic dysfunction was present. This study demonstrates that there is no evidence of a significant additional contribution to thrombotic risk (as assessed by plasma fibrinogen, von Willebrand factor and fibrin D-dimer) for patients with left ventricular diastolic dysfunction. A relationship is noted between some prothrombotic factors and Doppler indices of flow, which suggests a possible association between cardiac haemodynamics and thrombogenesis.
引用
收藏
页码:31 / 42
页数:12
相关论文
共 27 条
[1]  
Dougherty, Naccarelli, Gray, Hicks, Goldstein, Congestive heart failure with normal systolic function, Am J Cardiol, 54, pp. 778-782, (1984)
[2]  
Soufer, Wohlgelernter, Vita, Et al., Intact systolic left ventricular function in clinical congestive heart failure, Am J Cardiol, 55, pp. 1032-1036, (1985)
[3]  
Stroke Prevention in Atrial Fibrillation Investigators, Predictors of thromboembolism in atrial fibrillation I Clinical features of patients at risk, Annals of Internal Medicine, 116, pp. 1-5, (1992)
[4]  
Stroke Prevention in Atrial Fibrillation Investigators, Predictors of thromboembolism in atrial fibrillation II Echocardiographic features of patients at risk, Annals of Internal Medicine, 116, pp. 6-12, (1992)
[5]  
Cheng, Cardiac failure in coronary heart disease, Am Heart J, 120, pp. 396-412, (1990)
[6]  
Ernst, Resch, Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature, Ann Intern Med, 118, pp. 956-963, (1993)
[7]  
Lip, Fibrinogen and cardiovascular disorders, Q J Med, 88, pp. 155-165, (1995)
[8]  
Uchiyama, Takeuchi, Osawa, Et al., Platelet function tests in thrombotic cerebrovascular disorders, Stroke, 14, pp. 511-517, (1983)
[9]  
Jansson, Nilsson, Johnson, Von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death, Br Heart J, 66, pp. 351-355, (1991)
[10]  
Hunt, Rylatt, Hart, Bundesen, Serum crosslinked fibrin (XDP) and fibrinogen/fibrin degradation products (FDP) in disorders associated with activation of the coagulation or fibrinolytic systems, Br J Haematol, 60, pp. 715-722, (1985)